Single-cell Multi-omics and the Horizon of Clinical Utility

In August, we hosted the Tapestri scMRD for AML Summit in New York City – a day-long event with industry leaders to discuss the future of single-cell multi-omics in the clinic and beyond. Aaron Llanso, Sr. Director of Clinical Applications, started the day off and presented “Single-cell Multi-omics and the Horizon of Clinical Utility,” which includes:

• A brief overview of the Tapestri Platform technology
• An overview on the clinical opportunities of our scMRD technology
• A deeper dive into the Tapestri scMRD workflow